Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor

Background: Cardiotoxicity is one of the most serious chronic complications of anthracyclines therapy. Assessment of the left ventricular ejection fraction (LVEF) fails to detect subtle cardiac dysfunction of left ventricular (LV). This study aimed to detect and evaluate new parameters of subclinica...

Full description

Bibliographic Details
Main Authors: Hui-Min Hu, Xiao-Lin Zhang, Wei-Ling Zhang, Dong-Sheng Huang, Zhong-Dong Du
Format: Article
Language:English
Published: Wolters Kluwer 2018-01-01
Series:Chinese Medical Journal
Subjects:
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=12;spage=1450;epage=1456;aulast=Hu
_version_ 1818299718818594816
author Hui-Min Hu
Xiao-Lin Zhang
Wei-Ling Zhang
Dong-Sheng Huang
Zhong-Dong Du
author_facet Hui-Min Hu
Xiao-Lin Zhang
Wei-Ling Zhang
Dong-Sheng Huang
Zhong-Dong Du
author_sort Hui-Min Hu
collection DOAJ
description Background: Cardiotoxicity is one of the most serious chronic complications of anthracyclines therapy. Assessment of the left ventricular ejection fraction (LVEF) fails to detect subtle cardiac dysfunction of left ventricular (LV). This study aimed to detect and evaluate new parameters of subclinical anthracyclines' cardiotoxicity in children with solid tumor. Methods: A detailed echocardiographic examination was performed in 36 children with hepatoblastoma or rhabdomyosarcoma after receiving anthracyclines' chemotherapy and 36 healthy controls from January 2015 to December 2016. The LVEF, ratio of early diastolic peak velocity of transmitral flow (E) and septal diastolic e' mitral annular peak velocity (e'), tricuspid annular plane systolic excursion (TAPSE), and LV global longitudinal strain (GLS) were evaluated using M-mode, tissue Doppler imaging (TDI), and two-dimensional speckle tracking echocardiography (2D-STE), respectively. Echocardiographic parameters were compared between patient group and healthy controls. All patients were divided into two subgroups based on their anthracyclines' cumulative dosage (<300 mg/m2 subgroup and ≥300 mg/m2 subgroup). Results: All patients had no presentation of heart failure and LVEF within normal range (65.7 ± 5.1%). Compared with healthy controls, the mean E/e' increased significantly (7.9 ± 0.7 vs. 10.2 ± 3.5, t = 3.72, P < 0.01), mean TAPSE decreased significantly (17.2 ± 1.3 mm vs. 14.2 ± 3.0 mm, t = −4.03, P < 0.01), and mean LV GLS decreased significantly (−22.2% ± 1.9% vs. −17.9% ± 2.9%, t = -5.58, P < 0.01) in patient group. Compared with subgroup with anthracyclines' cumulative dosage < 300 mg/m2, mean LV GLS decreased significantly (−18.7 ± 2.7% vs. −16.5 ± 2.1%, t = 2.15, P = 0.04), the mean E/e' increased significantly (9.1 ± 1.5 vs. 11.5 ± 4.9, t = −2.17, P = 0.04), and mean TAPSE decreased significantly (14.2 ± 2.1 mm vs. 12.5 ± 2.2 mm, t = −2.82, P = 0.02) in subgroup with anthracyclines' cumulative dosage ≥300 mg/m2. Conclusions: LV GLS is helpful in the early detection of subclinical LV dysfunction using 2D-STE. E/e' and TAPSE are other sensitive parameters in detecting subclinical cardiac dysfunction of both ventricles by TDI. These parameters show significant change with different anthracyclines' cumulative dosage, so cumulative dosage should be controlled in clinical treatment.
first_indexed 2024-12-13T04:55:41Z
format Article
id doaj.art-5a8081b61b66465ebd611845b6501d68
institution Directory Open Access Journal
issn 0366-6999
language English
last_indexed 2024-12-13T04:55:41Z
publishDate 2018-01-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj.art-5a8081b61b66465ebd611845b6501d682022-12-21T23:58:54ZengWolters KluwerChinese Medical Journal0366-69992018-01-01131121450145610.4103/0366-6999.233950Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid TumorHui-Min HuXiao-Lin ZhangWei-Ling ZhangDong-Sheng HuangZhong-Dong DuBackground: Cardiotoxicity is one of the most serious chronic complications of anthracyclines therapy. Assessment of the left ventricular ejection fraction (LVEF) fails to detect subtle cardiac dysfunction of left ventricular (LV). This study aimed to detect and evaluate new parameters of subclinical anthracyclines' cardiotoxicity in children with solid tumor. Methods: A detailed echocardiographic examination was performed in 36 children with hepatoblastoma or rhabdomyosarcoma after receiving anthracyclines' chemotherapy and 36 healthy controls from January 2015 to December 2016. The LVEF, ratio of early diastolic peak velocity of transmitral flow (E) and septal diastolic e' mitral annular peak velocity (e'), tricuspid annular plane systolic excursion (TAPSE), and LV global longitudinal strain (GLS) were evaluated using M-mode, tissue Doppler imaging (TDI), and two-dimensional speckle tracking echocardiography (2D-STE), respectively. Echocardiographic parameters were compared between patient group and healthy controls. All patients were divided into two subgroups based on their anthracyclines' cumulative dosage (<300 mg/m2 subgroup and ≥300 mg/m2 subgroup). Results: All patients had no presentation of heart failure and LVEF within normal range (65.7 ± 5.1%). Compared with healthy controls, the mean E/e' increased significantly (7.9 ± 0.7 vs. 10.2 ± 3.5, t = 3.72, P < 0.01), mean TAPSE decreased significantly (17.2 ± 1.3 mm vs. 14.2 ± 3.0 mm, t = −4.03, P < 0.01), and mean LV GLS decreased significantly (−22.2% ± 1.9% vs. −17.9% ± 2.9%, t = -5.58, P < 0.01) in patient group. Compared with subgroup with anthracyclines' cumulative dosage < 300 mg/m2, mean LV GLS decreased significantly (−18.7 ± 2.7% vs. −16.5 ± 2.1%, t = 2.15, P = 0.04), the mean E/e' increased significantly (9.1 ± 1.5 vs. 11.5 ± 4.9, t = −2.17, P = 0.04), and mean TAPSE decreased significantly (14.2 ± 2.1 mm vs. 12.5 ± 2.2 mm, t = −2.82, P = 0.02) in subgroup with anthracyclines' cumulative dosage ≥300 mg/m2. Conclusions: LV GLS is helpful in the early detection of subclinical LV dysfunction using 2D-STE. E/e' and TAPSE are other sensitive parameters in detecting subclinical cardiac dysfunction of both ventricles by TDI. These parameters show significant change with different anthracyclines' cumulative dosage, so cumulative dosage should be controlled in clinical treatment.http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=12;spage=1450;epage=1456;aulast=HuAnthracyclines; Cardiotoxicity; Children; Echocardiography; Solid Tumor
spellingShingle Hui-Min Hu
Xiao-Lin Zhang
Wei-Ling Zhang
Dong-Sheng Huang
Zhong-Dong Du
Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
Chinese Medical Journal
Anthracyclines; Cardiotoxicity; Children; Echocardiography; Solid Tumor
title Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
title_full Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
title_fullStr Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
title_full_unstemmed Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
title_short Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
title_sort detection of subclinical anthracyclines cardiotoxicity in children with solid tumor
topic Anthracyclines; Cardiotoxicity; Children; Echocardiography; Solid Tumor
url http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=12;spage=1450;epage=1456;aulast=Hu
work_keys_str_mv AT huiminhu detectionofsubclinicalanthracyclinescardiotoxicityinchildrenwithsolidtumor
AT xiaolinzhang detectionofsubclinicalanthracyclinescardiotoxicityinchildrenwithsolidtumor
AT weilingzhang detectionofsubclinicalanthracyclinescardiotoxicityinchildrenwithsolidtumor
AT dongshenghuang detectionofsubclinicalanthracyclinescardiotoxicityinchildrenwithsolidtumor
AT zhongdongdu detectionofsubclinicalanthracyclinescardiotoxicityinchildrenwithsolidtumor